PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPyruvic acid
Pyruvic acid
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
154 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Type 2 diabetes mellitusD003924EFO_0001360E111—1114
Insulin resistanceD007333EFO_0002614E88.819—1—113
WartsD014860—B07—111—2
Erythrocyte transfusionD017707—————1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hemolytic anemiaD000743—D55-D59335—313
Inborn errors pyruvate metabolismD015323——223—613
AnemiaD000740EFO_0004272D64.9223—411
Pyruvate dehydrogenase complex deficiency diseaseD015325EFO_0007459E74.4121—37
Hemolytic anemia congenital nonspherocyticD000746————2—57
Sickle cell anemiaD000755EFO_0000697D57221—26
Hematologic diseasesD006402EFO_0005803D75.9—13——4
HemolysisD006461———11—24
Fatty liverD005234EFO_0003934———1—12
Open-angle glaucomaD005902EFO_0004190H40.1—11—12
Show 14 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471—C6177——114
NeoplasmsD009369—C8054——39
ShockD012769—R57.1—2——46
AdenocarcinomaD000230———3——14
Healthy volunteers/patients———31———4
GliomaD005910EFO_0000520—31———4
Breast neoplasmsD001943EFO_0003869C5021———3
Uterine cervical neoplasmsD002583——12———3
Cardiovascular diseasesD002318EFO_0000319I98—2——13
Ovarian neoplasmsD010051EFO_0003893C5611——13
Show 37 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Brain neoplasmsD001932EFO_0003833C714———15
Traumatic brain injuriesD000070642—S063————3
GlioblastomaD005909EFO_0000515—2————2
HyperglycemiaD006943—R73.91———12
Brain injuriesD001930—S06.92————2
HypertensionD006973EFO_0000537I101———12
CarcinomaD002277—C80.01———12
Wounds and injuriesD014947—T14.81———12
Cystic fibrosisD003550EFO_0000390E842————2
Pancreatic cystD010181—K86.21———12
Show 16 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Septic shockD012772—A48.3————55
FistulaD005402——————22
Pancreatic neoplasmsD010190EFO_0003860C25————22
SepsisD018805EFO_0001420A41.9————22
AcidosisD000138EFO_1000014E87.2————22
Melas syndromeD017241EFO_0000192E88.41————22
Hemolytic anemia congenitalD000745—D58.9————22
Coronary artery diseaseD003324—I25.1————22
Hemophilia bD002836—D67————11
Barth syndromeD056889Orphanet_111E78.71————11
Show 64 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use